Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Serie:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Soggetti:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Accesso online:https://www.rpcardio.com/jour/article/view/1769
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi